keyword
MENU ▼
Read by QxMD icon Read
search

Cytoreduction surgery

keyword
https://www.readbyqxmd.com/read/29046901/chirurgia-e-management-delle-pazienti-anziane-affette-da-carcinoma-ovarico
#1
Paolo Scollo, Giuseppe Scibilia, Basilio Pecorino
The median life expectancy of population among industrialized countries has dramatically expanded in recent years. On the other hand, the risk of developing cancer increases with age.The treatment for gynaecological malignancies is well defined with respect to the surgery, radiation treatment and chemotherapy. However, elderly patients receives substandard treatment when compared to the younger people, generally due to the presence of associated medical conditions. The assessment of the co-morbidity is an important aspect of the surgical decision-making process...
2017: Argom Oncol Geriatr
https://www.readbyqxmd.com/read/29034309/metastatic-uterine-tumor-resembling-ovarian-sex-cord-tumor-a-case-report-and-review-of-the-literature
#2
Michelle L Kuznicki, Sharon E Robertson, Ardeshir Hakam, Mian M Shahzad
Uterine tumors resembling ovarian sex cord tumors (UTROSCTs) are rare and commonly characterized as benign tumors, with infrequent reports of metastasis and recurrence. Treatment recommendations have not been well established, particularly for more advanced cases. We present the first reported death from a metastatic UTROSCT, summarize the available literature, and describe characteristics common to UTROSCTs with aggressive features. In this case, a 49-year-old woman presented with abdominal distension and pain; initial imaging and diagnostic workup suggested metastatic epithelial ovarian cancer to be the cause...
November 2017: Gynecologic Oncology Reports
https://www.readbyqxmd.com/read/29027138/recurrence-of-optimally-treated-malignant-peritoneal-mesothelioma-with-cytoreduction-and-heated-intraperitoneal-chemotherapy
#3
Danielle R Heller, Cody Chiuzan, Robert N Taub, Joshua C Leinwand, Allison M Greene, Gleneara E Bates, John A Chabot, Michael D Kluger
BACKGROUND: The prognosis for patients with diffuse malignant peritoneal mesothelioma has dramatically improved with cytoreductive surgery and intraperitoneal chemotherapy. Little is known about disease recurrence after treatment. We analyzed the time to and predictors of recurrence in a large cohort of optimally treated patients. METHODS: We examined 113 patients completing a two-stage cytoreduction and intraperitoneal chemotherapy protocol. All patients achieved optimal surgical resection with completeness of cytoreduction (CC) score ≤ 1 and were divided into two groups based on absence (Group A) or presence (Group B) of gross disease at the outset of the second operation...
October 12, 2017: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/29019736/clinical-and-laboratory-assessment-of-a-patient-with-thrombocytosis
#4
Niamh Appleby, Daniel Angelov
Elevated platelet counts are frequently encountered in hospital medicine and arise from both physiological and pathological mechanisms. Thrombocytosis may be secondary, reflecting an inflammatory state, iron deficiency, recent surgery or point towards an underlying neoplasm. Thrombocytosis may be the presenting sign of solid tumours and haematological conditions. The discovery of the activating mutations affecting thrombopoiesis led to greater understanding of the pathobiology of essential thrombocythaemia and other myeloproliferative neoplasms...
October 2, 2017: British Journal of Hospital Medicine
https://www.readbyqxmd.com/read/29019584/a-proposal-of-brazilian-society-of-surgical-oncology-for-standardizing-cytoreductive-surgery-plus-hypertermic-intraperitoneal-chemotherapy-procedures-in-brazil-pseudomixoma-peritonei-appendiceal-tumors-and-malignant-peritoneal-mesothelioma
#5
Thales Paulo Batista, Bruno José Queiroz Sarmento, Janina Ferreira Loureiro, Andrea Petruzziello, Ademar Lopes, Cassio Cortez Santos, Cláudio de Almeida Quadros, Eduardo Hiroshi Akaishi, Eduardo Zanella Cordeiro, Felipe José Fernández Coimbra, Gustavo Andreazza Laporte, Leonaldson Santos Castro, Ranyell Matheus Spencer Sobreira Batista, Samuel Aguiar, Wilson Luiz Costa, Fábio Oliveira Ferreira
Cytoreductive surgery plus hypertermic intraperitoneal chemotherapy has emerged as a major comprehensive treatment of peritoneal malignancies and is currently the standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome as well as malignant peritoneal mesothelioma. Unfortunately, there are some worldwide variations of the cytoreductive surgery and hypertermic intraperitoneal chemotherapy techniques since no single technique has so far demonstrated its superiority over the others...
September 2017: Revista do Colégio Brasileiro de Cirurgiões
https://www.readbyqxmd.com/read/29019118/frailty-correlates-with-postoperative-mortality-and-major-morbidity-after-cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy
#6
Ioannis T Konstantinidis, Konstantinos Chouliaras, Edward A Levine, Byrne Lee, Konstantinos I Votanopoulos
BACKGROUND: Frailty is increasingly being recognized as a powerful predictor of postoperative outcomes for cancer patients. This study examined the role of the modified frailty index (MFI) in predicting outcomes for patients undergoing cytoreduction (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). METHODS: Data from National Surgical Quality Improvement Program (NSQIP) patients who underwent CRS/HIPEC between 2005 and 2014 were reviewed. The MFI, validated for use in NSQIP, was used to determine correlation between frailty and postoperative outcomes...
October 10, 2017: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/29019111/institutional-experience-with-ostomies-created-during-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemoperfusion
#7
Sam Pakraftar, Lekshmi Ramalingam, Yongli Shuai, Heather L Jones, James F Pingpank, Steven S Ahrendt, Matthew P Holtzman, Amer H Zureikat, Herbert J Zeh, David L Bartlett, Haroon A Choudry
BACKGROUND: Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (CRS-HIPEC) is a complex procedure that often requires ostomy creation to protect high-risk anastomoses. This study aimed to evaluate the authors' institutional experience with CRS-HIPEC-associated ostomies, determine predictors of ostomy creation and reversal, and assess their impact on survival. METHODS: The study analyzed clinicopathologic, perioperative, and oncologic data from a prospective database of 1435 CRS-HIPEC procedures for peritoneal metastases...
October 10, 2017: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/29019106/antimicrobial-properties-of-perfusate-fluid-after-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-cs-hipec-with-mitomycin-c
#8
Krystle N Lange, Danielle McKay, Brian G Gentry, Jan Franko
BACKGROUND: Infectious postoperative complications often delay systemic chemotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS-HIPEC). Because the authors have empirically observed fewer incisional infectious complications than expected after CS-HIPEC with mitomycin C (MMC), they investigated the antimicrobial properties of HIPEC perfusate fluid. METHODS: This study prospectively measured in vitro bacterial growth inhibition by HIPEC perfusate (n = 18)...
October 10, 2017: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/29018838/adverse-post-operative-outcomes-in-jehovah-s-witnesses-with-gynecologic-cancer-within-30%C3%A2-days-of-surgery-a-single-institution-review-of-36-cases
#9
Laura J Moulton, Peter G Rose, Haider Mahdi
Rates of blood transfusion are reported as high as 32% in women undergoing major gynecologic cancer surgery. Therefore, care of the gynecologic oncology patient who refuses blood products, such as Jehovah's witnesses, can pose a unique challenge. The objective of this study was to determine rate of adverse post-operative outcomes within 30 days of surgery in Jehovah's witnesses with gynecologic cancer. This was a retrospective cohort study of Jehovah's witnesses undergoing laparotomy or minimally invasive surgery (MIS) for gynecologic cancer at a single institution...
November 2017: Gynecologic Oncology Reports
https://www.readbyqxmd.com/read/29017824/early-postoperative-intraperitoneal-chemotherapy-is-associated-with-survival-benefit-for-appendiceal-adenocarcinoma-with-peritoneal-dissemination
#10
Yeqian Huang, Nayef A Alzahrani, Winston Liauw, Hussein Soudy, Abdulaziz M Alzahrani, David L Morris
INTRODUCTION: The combined approach of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has achieved encouraging outcomes for patients with PMCA with peritoneal dissemination. However, there is little evidence for the use of EPIC in addition to HIPEC in this group of patients. PATIENTS AND METHODS: This was a retrospective study of prospectively collected data of consecutive patients with PMCA who underwent CRS and perioperative intraperitoneal chemotherapy by one surgical team at St George Hospital in Sydney, Australia between Jan 1996 and Aug 2016...
September 28, 2017: European Journal of Surgical Oncology
https://www.readbyqxmd.com/read/29017822/sub-optimal-primary-surgery-leads-to-unfavorable-immunological-changes-in-ovarian-cancer-patients
#11
Marek Nowak, Ewa Głowacka, Przemysław Lewkowicz, Małgorzata Banasik, Krzysztof Szyłło, Kinga Zimna, Katarzyna Bednarska, Magdalena Klink
Primary cytoreduction, followed by chemotherapy, is a standard treatment of patients with epithelial ovarian cancer (EOC). However, the effectiveness of this treatment depend on various elements e.g. type of operation. It is accepted that optimal surgery correlates with longer survival of patients. The other element, an efficiency of immune system after surgical intervention although important is less elucidated. The aim of this study was to establish the impact of optimal and sub-optimal operation on immunological status of EOC patients regarding also their overall survival (OS)...
October 5, 2017: Immunobiology
https://www.readbyqxmd.com/read/28993033/ca-19-9-to-peritoneal-carcinomatosis-index-pci-ratio-is-prognostic-in-patients-with-epithelial-appendiceal-mucinous-neoplasms-and-peritoneal-dissemination-undergoing-cytoreduction-surgery-and-intraperitoneal-chemotherapy-a-retrospective-cohort-study
#12
Mathew A Kozman, Oliver M Fisher, Bree-Anne J Rebolledo, Sarah J Valle, Nayef Alzahrani, Winston Liauw, David L Morris
BACKGROUND: Serum tumour levels have been shown to be prognostic in patients with epithelial appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei (PMP)). A singular index which incorporates both tumour activity (as depicted by serum tumour marker levels) and tumour volume (as depicted by peritoneal carcinomatosis index (PCI)), may give a more precise surrogate of tumour biological behaviour. The prognostic implication of this index has not yet been reported...
September 19, 2017: European Journal of Surgical Oncology
https://www.readbyqxmd.com/read/28991079/peritoneal-involvement-is-more-common-than-nodal-involvement-in-patients-with-high-grade-appendix-tumors-who-are-undergoing-prophylactic-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy
#13
Akash Mehta, Rohin Mittal, Kandiah Chandrakumaran, Norman Carr, Sanjeev Dayal, Faheez Mohamed, Brendan Moran, Tom Cecil
BACKGROUND: Right hemicolectomy is routinely recommended in patients with histologic findings of high-grade appendix tumors after appendicectomy. Undetected peritoneal disease may be encountered at surgery. In high-grade appendix tumors with disease detected radiologically, complete cytoreduction may not be possible and outcomes poor. For these reasons, we adopted a policy of prophylactic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. OBJECTIVE: The purpose of this study was to quantify the rates of peritoneal and nodal metastatic disease in patients with high-grade appendix tumors without obvious metastatic disease and to report the long-term outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in these patients...
November 2017: Diseases of the Colon and Rectum
https://www.readbyqxmd.com/read/28988028/intensive-care-admissions-among-ovarian-cancer-patients-treated-with-primary-debulking-surgery-and-neoadjuvant-chemotherapy-interval-debulking-surgery
#14
Kristen Pepin, Amy Bregar, Michelle Davis, Alexander Melamed, Emily Hinchcliff, Allison Gockley, Neil Horowitz, Marcela G Del Carmen
OBJECTIVE: Admissions to intensive care units (ICU) are costly, but are necessary for some patients undergoing radical cancer surgery. When compared to primary debulking surgery (PDS), neoadjuvant chemotherapy (NACT) with interval debulking surgery, is associated with less peri-operative morbidity. In this study, we compare rates, indications and lengths of ICU stays among ovarian cancer patients admitted to the ICU within 30days of cytoreduction, either primary or interval. METHODS: A retrospective chart review was performed of patients with stage III-IV ovarian cancer who underwent surgical cytoreduction at two large academic medical centers between 2010 and 2014...
October 4, 2017: Gynecologic Oncology
https://www.readbyqxmd.com/read/28986751/total-mesenteric-peritonectomy-for-peritoneal-metastases-with-video
#15
Jean-Baptiste Cazauran, Antoinette Lasseur, Arnaud Pasquer, Pascal Rousset, Jeremy Guedj, Guillaume Passot, Olivier Glehen
BACKGROUND: Complete cytoreductive surgery (CRS), combining organ resection and peritonectomy, is the only potentially curative treatment for patients with peritoneal metastases (PM).1 (,) 2 Diffuse mesenteric PM usually represents a contraindication for CRS.3 This report presents a standardized total mesenteric peritonectomy, which provides a therapeutic option of complete CRS for patients with diffuse mesenteric PM. PATIENT: A 73-year-old man had a diagnosis of PM caused by an urachal adenocarcinoma (signet cell type)...
October 6, 2017: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/28982894/recurrence-and-survival-outcomes-after-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-for-small-bowel-adenocarcinoma
#16
Akshat Saxena, Sarah J Valle, Winston Liauw, David L Morris
BACKGROUND: Peritoneal dissemination of small bowel adenocarcinoma (SBA) is rare but is associated with a dismal prognosis. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is a promising treatment option. We evaluated our experience of CRS-HIPEC for the treatment of SBA. PATIENTS AND METHODS: Sixteen consecutive patients underwent CRS-HIPEC for small bowel malignancy between 2003 and 2016. Clinopathological and treatment-related factors were obtained from a prospective database...
October 2017: Anticancer Research
https://www.readbyqxmd.com/read/28982890/debulking-surgery-for-clear-cell-carcinoma-of-the-ovary-a-case-report-and-literature-review
#17
REVIEW
Nicolae Bacalbasa, Irina Balescu, Alexandru Filipescu
Ovarian clear cell carcinoma represents a distinct histopathological subtype of epithelial ovarian cancer, with poor outcomes, especially in cases diagnosed in advanced stages of disease. However, even in these cases, it seems that the most effective treatment remains debulking surgery to no residual disease. We present the case of a 56-year-old patient diagnosed with a large pelvic mass invading the rectosigmoidal colon, and ileal loop who was successfully submitted to cytoreductive surgery to no residual disease...
October 2017: Anticancer Research
https://www.readbyqxmd.com/read/28979802/modulation-of-chemoresponsiveness-to-platinum-based-agents-by-micrornas-in-cancer
#18
REVIEW
Xin Yu, Heyi Zheng, Matthew Tv Chan, William Kk Wu
Ovarian cancer accounts for the highest mortality among all gynecologic cancers. Cytoreductive surgery followed by chemotherapy with a platinum-based agent (cisplatin or carboplatin) plus paclitaxel is the first-line option for treatment of epithelial ovarian cancer. However, primary or acquired resistance to platinum-based agents is a major clinical challenge. MicroRNAs are a group of small non-coding RNAs that regulate gene expression post-transcriptionally and may function as oncogenes or tumor-suppressor genes through extensive crosstalk with intracellular signaling pathways...
2017: American Journal of Cancer Research
https://www.readbyqxmd.com/read/28979717/stratification-of-outcomes-for-mucinous-appendiceal-adenocarcinoma-with-peritoneal-metastasis-by-histological-grade
#19
Travis Edward Grotz, Richard E Royal, Paul F Mansfield, Michael James Overman, Gary N Mann, Kristen Ashlee Robinson, Karen A Beaty, Safiea Rafeeq, Auerlio Matamoros, Michelle W Taggart, Keith Francis Fournier
AIM: To investigate the importance of a three-tiered histologic grade on outcomes for patients with mucinous appendiceal adenocarcinoma (MAA). METHODS: Two hundred and sixty-five patients with MAA undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy were identified from a prospective database from 2004 through 2014. All pathology was reviewed by our gastrointestinal subspecialty pathologists and histological grade was classified as well-differentiated, moderately differentiated, and poorly differentiated...
September 15, 2017: World Journal of Gastrointestinal Oncology
https://www.readbyqxmd.com/read/28978237/exploring-the-trend-in-referrals-for-consideration-of-crs-and-hipec-to-understand-the-attitudes-of-clinicians-in-the-development-of-a-national-cancer-centre-program-in-peritoneal-disease
#20
Weining Wang, Grace Hwei Ching Tan, Thakshayeni Skanthakumar, Claramae Shulyn Chia, Khee Chee Soo, Melissa Ching Ching Teo
INTRODUCTION: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) improve survival in selected patients with peritoneal metastases. However, only some patients who are potentially eligible for the procedure are considered and referred to the appropriate surgical department. By studying the trends of patients being considered for CRS and HIPEC in our center, we hope to better understand the demographics of our patient cohort and the attitudes of physicians involved towards CRS and HIPEC...
October 4, 2017: International Journal of Hyperthermia
keyword
keyword
25955
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"